Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.

doi:10.1038/s41586-021-04389-z

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.

Nature - 1 Feb 2022

Planas Delphine, Saunders Nell, Maes Piet, Guivel-Benhassine Florence, Planchais Cyril, Buchrieser Julian, Bolland William-Henry, Porrot Françoise, Staropoli Isabelle, Lemoine Frederic, Péré Hélène, Veyer David, Puech Julien, Rodary Julien, Baele Guy, Dellicour Simon, Raymenants Joren, Gorissen Sarah, Geenen Caspar, Vanmechelen Bert, Wawina-Bokalanga Tony, Martí-Carreras Joan, Cuypers Lize, Sève Aymeric, Hocqueloux Laurent, Prazuck Thierry, Rey Félix A, Simon-Loriere Etienne, Bruel Timothée, Mouquet Hugo, André Emmanuel, Schwartz Olivier

Abstract excerpt

The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and South Africa1-3. It has since spread to many countries and is expected to rapidly become dominant worldwide. The lineage is characterized by the presence of around 32 mutations in spike-located mostly in the N-terminal domain and the receptor-binding domain-that may enhance viral fitness and enable antibody evasion. Here we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibodies, Viral

Share to Belgium

Share to Immune Evasion

Share to Immunization, Secondary

Share to Neutralization Tests

Share to SARS-CoV-2

Share to Travel

Source

Open in PubMed

Identifiers

PMID: 35016199
DOI: 10.1038/s41586-021-04389-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.PMID 35016199Read ↗

Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralizationSemantic proximity Read ↗

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2.Semantic proximity Read ↗

Striking Antibody Evasion Manifested by the Omicron Variant of SARS-CoV-2Semantic proximity Read ↗

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesSemantic proximity Read ↗

Antibody evasion properties of SARS-CoV-2 Omicron sublineagesSemantic proximity Read ↗

Antibody Evasion Properties of SARS-CoV-2 Omicron SublineagesSemantic proximity Read ↗

COVID‐19: Omicron – the latest, the least virulent, but probably not the last variant of concern of SARS‐CoV‐2Semantic proximity Read ↗

Delineating antibody escape from Omicron sublineagesSemantic proximity Read ↗

SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concernSemantic proximity Read ↗

Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants, including Omicron sublineagesSemantic proximity Read ↗

Differential escape of neutralizing antibodies by SARS-CoV-2 Omicron and pre-emergent sarbecovirusesSemantic proximity Read ↗

Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variantsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.